Santaris Pharma and Pfizer have extended their collaboration pact to discover, develop and commercialize RNA-targeted medicines using Santaris Pharma Locked Nucleic Acid Drug Platform.
129123
Santaris Pharma, Pfizer extend collaboration pact
142492
'Microbes can be patented'
28106
Incyte says psoriasis drug meets main goal
73557
Obesity drug sails through trials
134679
Cadila Healthcare inks drug discovery pact with Eli Lilly
103821
Pharmaniaga's concession extended
159220
Hilti launches partnership agreement
80180
Novartis buys rights to new antibiotic
166022
CollabRx and OncoDNA announce multi-year agreement
155748
Drug company stands to benefit from legislation
44826
Phlexglobal announces partnership with Arkivum
69958
Alimera Sciences resubmits new drug application
128654
MDRNA buys DNA technology from Valeant Pharmaceuticals for undisclosed amount
149265
It, pharma continue to look good:
110579
Scientists harness new drug discovery tool to treat diabetes
16901
J&J wins approval for expanded use of HIV drug
175864
Bristol-Myers Squibb establishes strategic partnership with PAREXEL to enable greater effectiveness